Coldstream Capital Management Inc Monte Rosa Therapeutics, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 355 shares of GLUE stock, worth $1,643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
355Holding current value
$1,643% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GLUE
# of Institutions
109Shares Held
53.1MCall Options Held
117KPut Options Held
15.9K-
Nea Management Company, LLC Timonium, MD7.69MShares$35.6 Million3.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.64MShares$30.8 Million0.0% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$26.2 Million54.61% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$22.8 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.35MShares$20.1 Million0.44% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $216M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...